12 Best Large Biotech Stocks to Buy Now
Biotech companies are research science-driven companies focusing on novel drug development and clinical research with aims to treat diseases and medical conditions.
Posts Tagged ‘NASDAQ:VRTX’
Is Vertex Pharmaceuticals (VRTX) A Good Stock To Buy Now?
In this article we are going to use hedge fund sentiment as a tool and determine whether Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is a good investment right now.
Hedge Fund and Insider Trading News: Carl Icahn, Dan Loeb, Bill Ackman, Anchorage Capital, Vertex Pharmaceuticals Incorporated (VRTX), Estee Lauder Companies Inc (EL), and More
Activist investor Carl Icahn had an abysmal third quarter.
Were These Hedge Funds Right About Selling Vertex Pharmaceuticals Incorporated (VRTX)?
Many prominent investors, including Warren Buffett, David Tepper and Stan Druckenmiller, have been cautious regarding the current bull market and missed out as the stock market...
Here is What Hedge Funds Think About Vertex Pharmaceuticals Incorporated (VRTX)
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies.
Were Hedge Funds Right About Vertex Pharmaceuticals Incorporated (VRTX)?
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming).
Hedge Funds Have Never Been This Bullish On Vertex Pharmaceuticals (VRTX)
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Vertex Pharmaceuticals (VRTX): Were Hedge Funds Right About This Stock?
We hate to say this but, we told you so.
Hedge Funds Piled Into Vertex Pharmaceuticals (VRTX) Just In Time
Coronavirus is probably the #1 concern in investors’ minds right now. It should be.
Vertex Pharmaceuticals Incorporated (VRTX) vs. Hedge Fund Favorites in 2019
We are still in an overall bull market and many stocks that smart money investors were piling into surged in 2019.
Hedge Funds Are Warming Up To Vertex Pharmaceuticals Incorporated (VRTX)
The 700+ hedge funds and famous money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the third quarter, which unveil their equity...
Were Hedge Funds Right About Dumping Vertex Pharmaceuticals Incorporated (VRTX)?
Hedge fund managers like David Einhorn, Bill Ackman, or Carl Icahn became billionaires through reaping large profits for their investors, which is why piggybacking their stock...
Is Vertex Pharmaceuticals Incorporated (VRTX) A Good Stock To Buy?
Is Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) a good bet right now? We like to analyze hedge fund sentiment before doing days of in-depth research.
Is Vertex Pharmaceuticals Incorporated (VRTX) A Good Stock To Buy?
Like everyone else, elite investors make mistakes. Some of their top consensus picks, such as Amazon, Facebook and Alibaba, have not done well in Q4 due to various reasons.
Should You Avoid Vertex Pharmaceuticals Incorporated (VRTX)?
Our extensive research has shown that imitating the smart money can generate significant returns for retail investors, which is why we track more than 700 prominent money managers...
Billionaire Fund Managers Are Bullish On These Biotech Stocks
The biotech sector is well known for its M&A activity, but billionaire fund managers don’t seem to be attracted by the frenzy.
Here’s What Is Going On In The Financial Markets Today
“U.S. stocks traded mostly higher Wednesday, with energy leading, as investors digested economic data and the start of the United Kingdom's divorce from the European Union.
Vertex Pharmaceuticals Incorporated (VRTX) Surges On Study Results
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) shares have popped almost 19% in the pre-market after the company released positive results from two studies.
Is Vertex Pharmaceuticals Incorporated (VRTX) Going to Burn These Hedge Funds?
Hedge fund managers like David Einhorn, Dan Loeb, or Carl Icahn became billionaires through reaping large profits for their investors, which is why piggybacking their stock picks...
10 Most Successful Innovative Companies in The World in 2016
Bringing something new to the table is something that seems to be difficult these days, considering that many things have already been done, have already been invented, and have...
Five Healthcare Stocks that Disappointed Hedge Funds
There probably is no other sector that has burned hedge funds this year as bad as healthcare has.
Should You Follow Smart Money Into Vertex Pharmaceuticals Incorporated (VRTX)?
There are several ways to beat the market, and investing in small cap stocks has historically been one of them.
Here’s Why These Four Stocks Are Trending Today
It's the start of another week of what should amount to compelling trading activity and shares of Amazon.com, Inc.
A Look at the Developments Behind the Big Moves of Five Stocks
With the earnings season in progress, a number of stocks are registering significant moves on the back of earnings releases and other news.
Vertex Pharmaceuticals Incorporated (VRTX): Hal Mintz, David Shaw, and Phill Gross Are Big Winners
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is up more than 42% after reporting successful results of its cystic fibrosis treatment.
Outerwall, Pandora & Achillion All Targets of Mega-Hedge Funds
Outerwall, Pandora, Achillion, hedge funds: It’s no secret that at Insider Monkey, we track hedge funds (discover why here).
4 Health-Care Industry Predictions for the Next 20 Years
It's really amazing to think about how far we've come over even the past decade in the health-care arena.
Hedge Fund News: Ray Dalio, Stanley Druckenmiller & Nouriel Roubini’s Recommendation
Ray Dalio manages the world's largest hedge fund, Bridgewater Associates. It has a tremendous track record, so when the man talks about markets, people usually listen.
Vertex Pharmaceuticals Incorporated (VRTX), Merck & Co., Inc. (MRK), Rockwell Medical Inc (RMTI): Three Drug Classes That May Become Obsolete Within Three Years
There are few, if any, businesses in the world where innovation isn't the top priority.
One Contrarian Reason to Like Advanced Micro Devices, Inc. (AMD) and SAIC, Inc. (SAI)
Yesterday, shareholders in chipmaker Advanced Micro Devices, Inc. (NYSE:AMD) and defense contractor SAIC, Inc. (NYSE:SAI) got what seemed like bad news.
Hedge Fund Bets On Onyx Pharmaceuticals, Inc. (ONXX)
As fast as we can type this, Phill Gross and Robert Atchinson's hedge fund, Adage Capital Partners, disclosed ownership of about 3.7 million shares of Onyx Pharmaceuticals, ...
Should You Buy Regeneron Pharmaceuticals Inc (REGN)?
If you were to ask many investors, hedge funds are viewed as delayed, outdated investment vehicles of an era lost to time.
Vertex Pharmaceuticals Incorporated (VRTX), Merck & Co., Inc. (MRK): Gilead Sciences, Inc. (GILD) Races Against Competitors for an Oral Hepatitis-C Cure
One of the company's ushering in the next generation of hepatitis-C treatment is Gilead Sciences, Inc. (NASDAQ:GILD).
What Hedge Funds Think About Vertex Pharmaceuticals Incorporated (VRTX)
In the 21st century investor’s toolkit, there are tons of metrics market participants can use to track the equity markets.
Onyx Pharmaceuticals, Inc. (ONXX) Investors: Listen Up
In the 21st century investor’s toolkit, there are tons of metrics shareholders can use to track publicly traded companies.
Do Hedge Funds and Insiders Love Alexion Pharmaceuticals, Inc. (ALXN)?
In the 21st century investor’s toolkit, there are dozens of indicators investors can use to analyze Mr. Market.
Hedge Funds Are Crazy About BioMarin Pharmaceutical Inc. (BMRN)
In the financial world, there are dozens of gauges shareholders can use to analyze stocks. Two of the most under-the-radar are hedge fund and insider trading sentiment.
Is Illumina, Inc. (ILMN) Going to Burn These Hedge Funds?
If you were to ask many investors, hedge funds are assumed to be useless, old investment tools of a period lost to current times.
Exelixis, Inc. (EXEL), Vertex Pharmaceuticals Incorporated (VRTX), Celgene Corporation (CELG): Want Multibaggers? Consider These 3 Biotech Companies
In after hours trading on April 18, a few hours after the release of my previous article focusing on Exelixis, Inc.
Dendreon Corporation (DNDN), Vertex Pharmaceuticals Incorporated (VRTX): The Rise and Fall of the Fastest Growing Drug in the World
If you've ever taken the time to really follow the biopharmaceutical sector, you know very well that failures are a dime a dozen, and success stories are few and far between.
Vertex Pharmaceuticals Incorporated (VRTX), Green Mountain Coffee Roasters Inc. (GMCR): Stocks That Could Become Tomorrow’s Big S&P Winners
The S&P 500 includes 500 of the biggest stocks in the market.
3D Systems Corporation (DDD), Synovus Financial Corp. (SNV), Vertex Pharmaceuticals Incorporated (VRTX): These “Pure Growth” Stocks Have Been Trouncing the Market
Exchange-traded funds offer a convenient way to invest in sectors or niches that interest you.
Vertex Pharmaceuticals Incorporated (VRTX): This Biotech’s Cystic Fibrosis Treatments Could Catapult It To Profitability
Cystic fibrosis (CF), a genetic disorder that affects the lungs, the pancreas, liver, and intestine, is the second most common inherited disorder in the United States, after sickle...
Array Biopharma Inc (ARRY), Vertex Pharmaceuticals Incorporated (VRTX): This Week in Biotech
With the SPDR S&P Biotech Index up 29% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
Vertex Pharmaceuticals Incorporated (VRTX), Accelerate Diagnostics Inc (AXDX), Lifevantage Corporation (LFVN) – Pharmaceuticals: One Short, One Buy, One Strong Buy
Biotechnology stocks are usually valued on the potential of their pipelines, especially if there is no drug already in the market.
Gilead Sciences, Inc. (GILD) 2 Wins for Gilead: HIV Present, HCV Future
Gilead Sciences, Inc. (NASDAQ:GILD)' shares surged over 5% in after-hours trading on Thursday after the company announced its second-quarter earnings before giving up some of...
Three Key Takeaways From Johnson & Johnson (JNJ)’s Q2
Johnson & Johnson (NYSE:JNJ) reported its second quarter on Tuesday, and turned in some positive numbers. Revenue grew 8.5%, year-over-year, up to $17.9 billion.
Johnson & Johnson (JNJ) Stock Is Always a Buy (If You Hold Long Enough)
To prove my point, I looked at the multi-year chart and picked out some of the peaks.
Hewlett-Packard Company (HPQ), Sony Corporation (ADR) (SNE): Can These Companies Continue Their Bull Run?
When the stock price of a company increases significantly, investors are curious to know whether it is likely to increase further.
Abbott Laboratories (ABT), AbbVie Inc (ABBV): This FDA Approval Is Exciting News for Hepatitis-C Patients
Hepatitis-C is a contagious virus that attacks the liver and can be found in acute or chronic forms.
